Weinberg Jonathan 4
4 · Evolent Health, Inc. · Filed Aug 26, 2024
Insider Transaction Report
Form 4
Weinberg Jonathan
General Counsel
Transactions
- Exercise/Conversion
Class A Common Stock
2024-08-22$13.95/sh+25,253$352,279→ 192,280 total - Sale
Class A Common Stock
2024-08-22$30.00/sh−16,887$506,610→ 167,027 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2024-08-22−25,253→ 0 totalExercise: $13.95Exp: 2028-02-01→ Class A Common Stock (25,253 underlying) - Sale
Class A Common Stock
2024-08-22$32.00/sh−25,253$808,096→ 167,027 total - Exercise/Conversion
Class A Common Stock
2024-08-22$17.00/sh+16,887$287,079→ 183,914 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2024-08-22−16,887→ 0 totalExercise: $17.00Exp: 2025-06-04→ Class A Common Stock (16,887 underlying)
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2024.
- [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F3]The Class A Common Stock Options exercised vested on February 1, 2019, February 1, 2020, February 1, 2021, and February 1, 2022.
- [F4]The Class A Common Stock Options exercised vested on June 4, 2016, June 4, 2017, June 4, 2018, and June 4, 2019.